High Telomerase RNA Expression Level Is an Adverse Prognostic Factor for Favorable-Histology Wilms' Tumor
- 20 December 2005
- journal article
- pediatric oncology
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (36) , 9138-9145
Abstract
Purpose: A primary objective of the fifth National Wilms Tumor Study (NWTS-5) was to identify prognostic indicators for patients with favorable-histology Wilms' tumor. The prognostic significance of telomerase expression level in primary tumor samples was assessed. Patients and Methods: A case-cohort study was conducted involving 291 NWTS-5 registrants. Telomerase activity was measured using the telomeric repeat amplification protocol (TRAP). Expression levels of TERT mRNA (encoding the telomerase catalytic component) and TERC/hTR (the telomerase RNA template) were measured using quantitative real-time polymerase chain reaction. Results: After excluding samples because of lack of viable tumor, RNA degradation, or insufficient clinical information, 244 patients remained for the final analysis (96 with relapse and 148 without relapse). Univariate analysis revealed a positive correlation between relative risk (RR) of relapse and levels of TERT mRNA and TERC expression. For each doubling in TERT mRNA and TERC level, the RR increased by a factor of 1.16 (95% CI, 1.04 to 1.29; P = .01) and 1.35 (95% CI, 1.11 to 1.64; P = .003), respectively. The one third of patients whose tumors had the highest TERC expression level had an RR of 2.06 (95% CI, 1.14 to 3.70; P = .02) compared with patients with the lowest level. TERC expression level remained a significant prognostic indicator in a multivariate analysis adjusting for TERT mRNA, tumor stage, and patient age. TRAP level did not correlate with RR of relapse. Telomerase expression levels were not predictive of overall survival. Conclusion: Telomerase RNA expression level may provide a clinically useful adjunct to the current risk classification schema for favorable-histology Wilms' tumor.Keywords
This publication has 49 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progressionGenes & Development, 2003
- Mutational analysis defines a minimum level of telomerase activity required for tumourigenic growth of human cellsOncogene, 2002
- Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosisOncogene, 1998
- Telomerase Catalytic Subunit Homologs from Fission Yeast and HumanScience, 1997
- A survey of telomerase activity in human cancerEuropean Journal of Cancer, 1997
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- New telomeres in yeast are initiated with a highly selected subset of TG1-3 repeats.Genes & Development, 1993
- Cox Regression with Incomplete Covariate MeasurementsJournal of the American Statistical Association, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958